Gemcitabine trials for NSCLC

All Gemcitabine trials · All NSCLC trials

Phase breakdown

Recruiting trials studying Gemcitabine for NSCLC

• BBO-11818 in Adult Subjects With KRAS Mutant Cancer
  NCT06917079 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 17 locations
• LUNG-05: Investigating Chemotherapy Effectiveness for Non-Small Cell Lung Cancer (NSCLC) Metastatic Patients
  NCT06576635 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
  NCT05786924 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 27 locations

Common questions

How many trials study Gemcitabine for NSCLC?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.